Richard Hopkins
Follow
Follow Organisations, People and Lists
Stay on top of the latest updates for your desired data.
Richard Hopkins
Managing Director / Zelira Therapeutics
Richard Hopkins is a founder of Phylogica and had been the chief executive since July 2013; he announced his resignation in July 2016. His most recent research was focused on engineering peptide leads for drug development. Dr Hopkins has published over 20 peer reviewed papers and is a co-inventor on over 10 patent applications.
Lists and Charts
Total Shareholder Return as at 31/07/20
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 16th | Ultima United | 780% | 38% |
| 479th | 4DS Memory | -7% | 9% |
| 606th | Zelira Therapeutics | -26% | 31% |
673 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 146th |  | Zelira Therapeutics | $769k |
| 176th | | Cervantes Corporation | $76k |
| 177th |  | Pura Vida Energy | $74k |
| 180th | | 4DS Memory | $39k |
| 181st | | Ultima United | $33k |
199 listed industrial companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Person Activity
| REMUNERATION UPDATE: Co-Founder, Chief Executive, PYC Therapeutics | 30 Jun 2020 |
| REMUNERATION UPDATE: Chief Executive Officer, PharmAust | 30 Jun 2020 |
